Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Deakin

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPPM R Ranson, J A Radford, R Swindell, et al.
Blood|September 15, 1992
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trialR Pettengell, H Gurney, J A Radford, et al.
British Journal of Haematology|October 1, 1991
Post consolidation therapy for adult patients with acute myeloid leukaemiaM R Ranson, J H Scarffe, G R Morgenstern, et al.
Bone Marrow Transplantation|January 1, 1989
The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an updateJ Chang, G R Morgenstern, L H Coutinho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre studyJ Shamash, S M Lee, J A Radford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphomaR Pettengell, J A Radford, G R Morgenstern, et al.
Cancer|February 1, 1988
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factorsW P Steward, D Crowther, L J McWilliam, et al.
European Journal of Cancer|May 1, 1979
Evaluation of adjuvant therapy in soft tissue sarcoma. A collaborative multidisciplinary approach. E.O.R.T.C. protocol 62771H M Pinedo, C P Vendrik, V H Bramwell, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPPM R Ranson, J A Radford, R Swindell, et al.
Blood|September 15, 1992
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trialR Pettengell, H Gurney, J A Radford, et al.
British Journal of Haematology|October 1, 1991
Post consolidation therapy for adult patients with acute myeloid leukaemiaM R Ranson, J H Scarffe, G R Morgenstern, et al.
Bone Marrow Transplantation|January 1, 1989
The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an updateJ Chang, G R Morgenstern, L H Coutinho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre studyJ Shamash, S M Lee, J A Radford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphomaR Pettengell, J A Radford, G R Morgenstern, et al.
Cancer|February 1, 1988
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factorsW P Steward, D Crowther, L J McWilliam, et al.
European Journal of Cancer|May 1, 1979
Evaluation of adjuvant therapy in soft tissue sarcoma. A collaborative multidisciplinary approach. E.O.R.T.C. protocol 62771H M Pinedo, C P Vendrik, V H Bramwell, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Pageof 5